147 related articles for article (PubMed ID: 29058490)
21. Population-based survival from cancers having a poor prognosis in Mumbai (Bombay), India.
Yeole BB; Kumar AV
Asian Pac J Cancer Prev; 2004; 5(2):175-82. PubMed ID: 15244521
[TBL] [Abstract][Full Text] [Related]
22. Does long-term survival exist in pancreatic adenocarcinoma?
Zijlstra M; Bernards N; de Hingh IH; van de Wouw AJ; Goey SH; Jacobs EM; Lemmens VE; Creemers GJ
Acta Oncol; 2016; 55(3):259-64. PubMed ID: 26559995
[TBL] [Abstract][Full Text] [Related]
23. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
[TBL] [Abstract][Full Text] [Related]
24. Survival analysis of veteran patients with pancreatic cancer.
Kim D; Zhu H; Nassri A; Mokdad A; Kukreja S; Polanco P; Huerta S; Ramzan Z
J Dig Dis; 2016 Jun; 17(6):399-407. PubMed ID: 27235863
[TBL] [Abstract][Full Text] [Related]
25. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
26. Resection rate and outcome of pulmonary resections for non-small-cell lung cancer: a nationwide study from Iceland.
Thorsteinsson H; Alexandersson A; Oskarsdottir GN; Skuladottir R; Isaksson HJ; Jonsson S; Gudbjartsson T
J Thorac Oncol; 2012 Jul; 7(7):1164-9. PubMed ID: 22592213
[TBL] [Abstract][Full Text] [Related]
27. Incidence and mortality of pancreatic cancer in the Nordic countries 1971-2000.
Nagenthiraja K; Ewertz M; Engholm G; Storm HH
Acta Oncol; 2007; 46(8):1064-9. PubMed ID: 17952708
[TBL] [Abstract][Full Text] [Related]
28. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods.
Engholm G; Gislum M; Bray F; Hakulinen T
Acta Oncol; 2010 Jun; 49(5):545-60. PubMed ID: 20491523
[TBL] [Abstract][Full Text] [Related]
29. [Incidence, diagnosis, treatment and prognosis of cancer of the pancreas: development in Côte-d'Or from 1976 to 1985].
Moutet JP; Arveux P; Kurdi E; Hillon P; Faivre J
Bull Cancer; 1991; 78(4):323-30. PubMed ID: 1859901
[TBL] [Abstract][Full Text] [Related]
30. Treatment patterns and outcomes for pancreatic tumors in children: an analysis of the National Cancer Database.
Picado O; Ferrantella A; Zabalo C; Rao K; Thorson CM; Sola JE; Perez EA
Pediatr Surg Int; 2020 Mar; 36(3):357-363. PubMed ID: 31989243
[TBL] [Abstract][Full Text] [Related]
31. Incidence and relative survival of pancreatic adenocarcinoma and pancreatic neuroendocrine neoplasms in Germany, 2009-2018. An in-depth analysis of two population-based cancer registries.
Stang A; Wellmann I; Holleczek B; Fell B; Terner S; Lutz MP; Kajüter H
Cancer Epidemiol; 2022 Aug; 79():102204. PubMed ID: 35777306
[TBL] [Abstract][Full Text] [Related]
32. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.
Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J
Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288
[TBL] [Abstract][Full Text] [Related]
33. Time-trends in incidence and prognosis of hepatocellular carcinoma in Denmark: A nationwide register-based cohort study.
Jepsen P; Andersen MW; Villadsen GE; Ott P; Vilstrup H
Liver Int; 2017 Jun; 37(6):871-878. PubMed ID: 27943604
[TBL] [Abstract][Full Text] [Related]
34. Lung Cancer Epidemiology in Korea.
Shin A; Oh CM; Kim BW; Woo H; Won YJ; Lee JS
Cancer Res Treat; 2017 Jul; 49(3):616-626. PubMed ID: 27669705
[TBL] [Abstract][Full Text] [Related]
35. [Pancreas multidisciplinary team optimizes the diagnosis and treatment of pancreas-related diseases and improves the prognosis of pancreatic cancer patients].
Li JA; Xu YL; Ding N; Ji Y; Liu LX; Rao SX; Zhang YQ; Yao XZ; Fan Y; Huang C; Zhou YH; Wu LL; Dong Y; Zhang L; Rong YF; Kuang TT; Xu XF; Liu L; Wang DS; Jin DY; Lou WH; Wu WC
Zhonghua Wai Ke Za Zhi; 2022 Jul; 60(7):666-673. PubMed ID: 35775259
[No Abstract] [Full Text] [Related]
36. Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001.
Mohagheghi MA; Mosavi-Jarrahi A; Malekzadeh R; Parkin M
Arch Iran Med; 2009 Jan; 12(1):15-23. PubMed ID: 19111024
[TBL] [Abstract][Full Text] [Related]
37. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study.
Saad AM; Turk T; Al-Husseini MJ; Abdel-Rahman O
BMC Cancer; 2018 Jun; 18(1):688. PubMed ID: 29940910
[TBL] [Abstract][Full Text] [Related]
38. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States).
Cress RD; Yin D; Clarke L; Bold R; Holly EA
Cancer Causes Control; 2006 May; 17(4):403-9. PubMed ID: 16596292
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of cancer incidence and mortality in Henan province, 2009].
Zhang JG; Liu SZ; Chen Q; Quan PL; Lu JB; Sun XB
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Jul; 47(7):597-602. PubMed ID: 24304950
[TBL] [Abstract][Full Text] [Related]
40. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006.
Bray F; Klint A; Gislum M; Hakulinen T; Engholm G; Tryggvadóttir L; Storm HH
Acta Oncol; 2010 Jun; 49(5):644-54. PubMed ID: 20151937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
